Abbott launches the ICRAS Tool in India to help doctors detect heart and kidney risks early in people with type 2 diabetes, supporting better cardio-renal risk assessment and patient outcomes.
FDA expands approval of GSK’s Arexvy RSV vaccine to high-risk adults aged 18–49, widening protection against severe respiratory infections and supporting broader adult immunization strategies.
Deloitte India launches ConnectSafe, a first-of-its-kind cybersecurity facility enabling real-world cyber threat simulation to strengthen protection for connected systems and critical infrastructure.
WHO Foundation and Novo Nordisk have launched a collaboration in India to tackle childhood obesity through a school-based health program. The initiative will promote healthier lifestyles, early screening, and stronger health systems for children.
BPL Medical Technologies has launched advanced bone mineral density diagnostic systems in India and Dubai after acquiring YozmaBMtech, expanding its capabilities in osteoporosis screening, imaging technology, and preventive healthcare.
Shilpa Biologicals and partner mAbTree Biologics AG secured FDA Orphan Drug Designation for a novel monoclonal antibody targeting Essential Thrombocythemia and Polycythemia Vera, marking a key step toward new treatments for rare blood cancers.
Zydus Lifesciences has launched Diasens and GlucoLive, its new AI-powered continuous glucose monitoring devices. The system streams real-time glucose data to smartphones and connects patients, caregivers, and doctors through the GoodFlip digital care
Roche Pharma India and the Punjab government launched NeuroSakhi, a patient support initiative for women with multiple sclerosis, aiming to improve early diagnosis, care pathways, and long-term treatment access.
Pfizer reported encouraging Phase 2 results for tilrekimig, a trispecific antibody for moderate to severe atopic dermatitis. The drug improved EASI-75 response rates and showed strong efficacy with monthly dosing.
Merck and Cyto-Facto sign an MoU to accelerate cell and gene therapy manufacturing in APAC, focusing on Japan and India, with a goal to improve patient access to therapies.
.jpg)
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")